8-K: Vivakor Faces Nasdaq Delisting Over Bid Price, Shareholder Rules

Vivakor, Inc. is facing delisting from The Nasdaq Capital Market due to persistent failure to meet minimum bid price requirements and a violation of shareholder approval rules.

Summary

• Vivakor received a notification from Nasdaq on December 19, 2025, advising of its delisting from The Nasdaq Capital Market.
• The primary reason for delisting is the common stock's closing bid price falling to $0.10 or less for ten consecutive trading days, triggering Nasdaq's Low Priced Stocks Rule (5810(c)(3)(A)(iii)).
• This low bid price made the company ineligible for the remainder of its Second Grace Period, which was initially granted until March 16, 2026, to regain compliance with the $1.00 Minimum Bid Price Requirement.
• An additional basis for delisting is the company's failure to comply with Nasdaq's shareholder approval requirements (Listing Rule 5635(d)) for transactions involving the issuance of 20% or more of pre-transaction shares outstanding at less than the Minimum Price.
• Trading of Vivakor's common stock was suspended at the opening of business on December 26, 2025.
• A Form 25-NSE will be filed with the SEC to remove the company's securities from listing and registration on The Nasdaq Stock Market.
• The company submitted an appeal to Nasdaq's determination on December 24, 2025, and a hearing has been scheduled for January 29, 2026.

Sentiment

Score: 1

Explanation: The filing indicates severe negative developments, including imminent delisting from Nasdaq, suspension of trading, and failure to meet multiple listing requirements. This represents a significant blow to the company's market standing and investor confidence.

Negatives

• The common stock's closing bid price fell to $0.10 or less for ten consecutive trading days as of December 19, 2025.
• Failed to regain compliance with Nasdaq's Minimum Bid Price Requirement of $1.00 per share.
• Violated Nasdaq's shareholder approval requirements (Rule 5635(d)) by issuing 20% or more of pre-transaction shares outstanding at less than the Minimum Price without prior shareholder approval.
• Trading of the common stock was suspended on December 26, 2025.
• The company is facing imminent delisting from The Nasdaq Capital Market.

Risks

• There is no assurance that the company will be successful in its appeal to the Nasdaq Hearings Panel.
• There is no assurance that the company will be able to regain compliance with Nasdaq's listing standards.
• Delisting from Nasdaq will likely result in reduced liquidity and investor interest for the company's common stock.
• The company may face challenges in raising capital in the future due to its delisted status.
• Reputational damage stemming from the delisting could negatively impact business operations and partnerships.

Future Outlook

The company is preparing a plan to regain compliance for its appeal hearing on January 29, 2026, but there is no assurance of success in the appeal or ability to regain compliance with Nasdaq listing standards.

Management Comments

• "The Company will provide the Hearings Panel with a plan to regain compliance, which the Company is in the process of preparing."
• "There can be no assurance, however, that the Company will be successful in its appeal to the Hearings Panel or be able to regain compliance with the listing standards discussed above."

Industry Context

The delisting of a company from a major exchange like Nasdaq typically signals significant operational or financial distress, often leading to reduced investor confidence and liquidity. Such events are closely watched by the market as indicators of a company's viability and adherence to regulatory standards, impacting its ability to compete and raise capital compared to its peers.

Comparison to Industry Standards

• Failure to maintain a minimum bid price of $1.00 is a common reason for delisting from major exchanges like Nasdaq, affecting numerous small-cap companies that struggle with market capitalization and investor interest.
• Violation of shareholder approval rules for significant share issuances at discounted prices, as seen with Vivakor, is a serious governance issue that can erode investor trust and is generally not tolerated by major exchanges, unlike companies that maintain robust corporate governance practices.
• Companies like Vivakor, facing delisting, often transition to over-the-counter (OTC) markets, which typically offer less liquidity and transparency compared to Nasdaq-listed peers, making it harder to attract institutional investment.

Corporate Governance

Legal Proceedings

• Regulatory proceedings with Nasdaq regarding non-compliance with listing rules, leading to a delisting notice and an appeal hearing.

Stakeholder Impact

• Shareholders: Significant negative impact due to delisting, suspension of trading, loss of liquidity, potential decrease in share value, and difficulty in trading shares.
• Company Management/Employees: Increased pressure to resolve compliance issues, potential impact on company morale and future operations.
• Creditors/Investors: Increased risk perception, potential difficulty in securing future financing.

Next Steps

• The company will provide the Nasdaq Hearings Panel with a plan to regain compliance.
• A hearing is scheduled for January 29, 2026, to appeal the delisting determination.
• A Form 25-NSE will be filed with the SEC to remove the company's securities from listing and registration on Nasdaq.

Key Dates

Recommendation

The imminent delisting from Nasdaq, coupled with the suspension of trading and failure to meet multiple critical listing requirements (minimum bid price and shareholder approval), signals severe operational and governance issues. The stock's value has plummeted to $0.10 or less, and while an appeal is pending, the likelihood of success and subsequent re-compliance appears low given the multiple deficiencies. This situation presents extreme risk, loss of liquidity, and significant uncertainty for investors, warranting a strong sell recommendation to mitigate further losses.

Keywords

Vivakor, VIVK, Nasdaq, Delisting, Minimum Bid Price, Shareholder Approval, Listing Rules, Suspension, Compliance, 8-K